文献速递头颈外科

放疗技术发展改善下咽癌肿瘤控制

Improved Tumor Control Related to Radiotherapy Technological Development for Hypopharyngeal Cancer.
PubMed 文献 · Laryngoscope · 2020-05-12

结果显示IMRT较2D-RT显著改善总生存、无进展生存和局部无复发生存,且急性毒性降低。

要点

  • IMRT较2D-RT显著改善24个月FFLR、PFS和OS。
  • 同步化疗使用自2000年代起增加(P < .001)。
  • IMRT与急性毒性降低相关。

核心结论

  • IMRT的引入与下咽癌局部无复发生存、无进展生存和总生存改善相关,并较早期放疗技术降低急性毒性。

主要发现

  • 2D-RT、3D-CRT和IMRT的24个月FFLR分别为52%、55%和80%。
  • 2D-RT、3D-CRT和IMRT的24个月PFS分别为39%、46%和73%。
  • 2D-RT、3D-CRT和IMRT的24个月OS分别为27%、40%和68%。
  • IMRT较2D-RT改善OS(P = .01)、PFS(P = .03)和FFLR(P = 0.02),FFLR较3D-CRT有改善趋势(P = .06)。
  • 控制化疗等因素后,IMRT对FFLR的调整HR = 0.2(95%CI:0.0-1.2,P = .08),对OS的调整HR = 0.1(95%CI:0.0-0.4,P = .005)。

临床怎么用

  • 在适合根治性放疗的下咽鳞癌中,优先考虑IMRT以改善肿瘤控制并降低急性毒性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: Squamous cell carcinoma of the hypopharynx (SCCHP) is associated with worse survival compared to other head and neck subsites. This report quantifies the impact of technological improvements in radiotherapy (RT) on outcomes over 6 decades. METHODS: Patients with SCCHP receiving curative-intent treatment between 1962 and 2015 were retrospectively reviewed. Kaplan-Meier analyses of freedom from local recurrence (FFLR), progression-free survival (PFS), and overall survival (OS) were compared across treatment eras and radiation techniques. Multivariable Cox proportional hazards modeling was performed to specify the effect of RT technique. RESULTS: One hundred thirty-four patients had a median follow-up of 17 months (IQR = 9-38). There were no differences in staging or use of surgery over time, but use of chemotherapy concurrent with RT increased (P < .001) beginning in the 2000s. The 24-month FFLR using two-dimensional RT (2D-RT), three-dimensional conformal RT (3D-CRT), and intensity-modulated RT (IMRT) was 52%, 55%, and 80%, respectively; 24-month PFS was 39%, 46%, and 73%, respectively; and 24-month OS was 27%, 40%, and 68%, respectively. OS (P = .01), PFS (P = .03), and FFLR (P = 0.02) were improved with IMRT over 2D-RT, and FFLR appeared to be improved over 3D-CRT (P = .06). Controlling for chemotherapy use and other major variables, IMRT produced a strong influence over FFLR (adjusted hazard ratio [HR] = 0.2, 95% confidence interval [CI]: 0.0-1.2, P = .08) and a benefit in OS (adjusted HR = 0.1, 95% CI: 0.0-0.4, P = .005). CONCLUSIONS: Across 6 decades, patient and tumor characteristics remained similar whereas use of chemoradiation increased and IMRT was adopted. The introduction of IMRT was associated with improved FFLR, PFS, and OS, and a reduction in acute toxicity as compared to earlier radiation technologies. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E452-E458, 2021.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Susko MS, Lazar AA, Dhar S, et al. Improved Tumor Control Related to Radiotherapy Technological Development for Hypopharyngeal Cancer. Laryngoscope. 2020. PMID: 32396214. doi:10.1002/lary.28726

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。